Product
Supplier
Encyclopedia
Inquiry
Home > News > Company Dynamic > Pfizer acquires biopharmaceutical company Global Blood Therapeutics (GBT)

Pfizer acquires biopharmaceutical company Global Blood Therapeutics (GBT)

ECHEMI 2022-08-16

Pfizer agreed to buy biopharmaceutical company Global Blood Therapeutics (GBT) for $5.4 billion. The acquisition of GBT will strengthen Pfizer's rare disease business and help it achieve its long-term goal of selling a treatment for sickle cell disease, Pfizer said.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Company-Dynamic
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.